Richard Porter

Richard Porter

Company: Corlieve Therapeutics

Job title: Chief Executive Officer

Seminars:

Q&A Panel Discussion: Exploring Different Genetic Approaches & Novel Targets for CNS Disorders 11:40 am

Read more

day: Day One

Gene Therapy Targeting Ectopically Expressed Kainate Receptors in Refractory Temporal Lobe Epilepsy 11:00 am

Ectopically expressed kainate receptors (KARs) trigger epileptic activity in refractory temporal lobe epilepsy Using an engineered miRNA approach knocking down ectopically expressed KARs suppresses spontaneous recurrent seizuresRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.